|
Glomerulonephritis is the commonest cause of kidney damage and failure of kidney function which may result in the need for dialysis (artificial kidney treatment) and/or a kidney transplant. There are many different types of glomerulonephritis but IgA Nephropathy is the most common type in Australia. It is found more often in males than females. About 10-30% of people with IgA Nephropathy have progressive deterioration of kidney function leading to what is called ireversible or end stage kidney (renal) failure. In Australia, 11% of all patients on dialysis have IgA Nephropathy.
While IgA Nephropathy occurs in all age groups, it is usually diagnosed before the age of 30 years. It is common in children but the peak incidence is between 15-25 years. Usually, the passage of blood in the urine (macroscopic haematuria) making it coffee or tea coloured, is one of the signs for which the person sees a doctor. This is usually associated with a sore throat or respiratory infection or diarrhoea and vomiting, and may occur again in association with such infections. In some people who may have very few symptoms of severe illness, the only clue may be the finding of blood cells or protein or both (these referred to as haematuria and proteinuria) in the urine on a routine urine test.
The final diagnosis of IgA Nephropathy can be made only a by kidney biopsy - after a local anaesthetic, a sample of kidney tissue is removed by a needle and then examined under a microscope.
IgA Nephropathy is sometimes called Berger's disease as a French doctor, Jean Berger, was the
first to describe it. Nephropathy simply means kidney disease. The antibody IgA (Immunoglobulin A),
derived from the lining of the throat, air passages and intestine is found in the kidney and has
caused damage to the kidney. The precise mechanism is not yet certain and is the subject of much
medical research. It is thought that some people produce too much IgA antibody when their body is
fighting infections of the throat, tonsils, lungs and intestines and yet the antibody produced is
not as efficient in eradicating the infection as it is in most people. As a result, the antibody
combines with the infecting organism (antigen), circulates in the blood and lodges in the glomerulus (the
filtering mechanism of the kidney) where it causes inflammation (nephritis) which may progress to more
severe kidney damage, recognised as IgA Nephropathy.
The majority of people with mild IgA Nephropathy have a good outlook and the disease may remit for
long periods or disappear altogether. Even these people however may suffer from episodes of obvious
blood in the urine if they develop another infection, and may develop high blood pressure and
deterioration of kidney function as they grow older.
In those with more severe damage to their kidneys (10-30%), kidney function declines and end-stage renal failure may occur within 3-30 years. In these people dialysis and/or kidney transplant will be required. IgA Nephropathy can occur in a transplanted kidney but in most cases this is in a mild form and does not significantly influence the function of the transplanted kidney.
Because of the uncertain outlook, it is recommended that all people found to have IgA Nephropathy, even in its mild form, should be seen by their general practitioner and kidney specialist at regular intervals. Indeed healthy individuals with the disease should have blood pressure checks and urine examinations made by their doctor from time to time to pick up the first signs of any problems.
Although not usually inherited, IgA Nephropathy has been found in members of the same family. So close relatives of a person with it should have their urine tested for blood and protein and a blood pressure check.
In those who have IgA Nephropathy regular tests of kidney function are necessary because progressive kidney failure can be detected by these tests. Even if someone with IgA Nephropathy appears to be stable, a regular review by a kidney specialist is important.
So far there is no curative treatment for IgA Nephropathy. At present the most promising treatments include blood pressure lowering agents (Angiotensin Converting Enzyme (ACE) Inhibitors, Angiotensin Receptor Antagonists (ARA's) and Calcium Channel Blockers). Appropriate treatment including antibiotics for infections and diet will help in many cases, as will restriction of alcohol and tobacco intake and control of cholesterol. There is some evidence supporting the use of fish oil supplements. Rarely, other drugs, such as steroids, cyclophosphamide and mycophenolate are used for nephrotic of more rapidly progressive IgA nephropathy.
However, if people have severe IgA Nephropathv, treatment with dialysis or a kidney transplant usually
allows them to continue to lead an active and satisfactory life.
RENAL RESOURCE CENTRE
37 Darling Point Road, Darling Point NSW 2027
Telephone: (02) 9362 3995 or (02) 9362 3121
Facsimile: (02) 9362 4354
Toll Free: 1800 257 189
Web: www.renalresource.com
Supported by the Australian Kidney Foundation